Stocks Health care IMTX
NASDAQ · Health careImmatics N.V. (IMTX)
It posted a net loss of €196.4M. In fiscal 2025 capital spending exceeded operating cash flow by €183.2M. At December 31, 2025 it held €345.9M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on March 5, 2026.
What Immatics N.V. does
Immatics N.V. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker IMTX.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -€196.4M | -€1.61 | -€183.2M |
| 2024 | n/a | €15.2M | €0.14 | -€174.3M |
| 2023 | n/a | -€94.6M | -€1.18 | -€12.6M |
| 2022 | n/a | €27.7M | €0.40 | €94.4M |
| 2021 | n/a | -€93.3M | -€1.08 | -€89.9M |
| 2020 | n/a | -€211.3M | -€3.20 | -€88.1M |
Latest SEC filings
What Immatics N.V. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 27, 2026Activist stake changed SCHEDULE 13D/A
- August 26, 2026
- August 25, 2026
- August 18, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- June 25, 2026
- June 18, 2026
- June 2, 2026
- June 1, 2026
- May 15, 2026Passive stake changed SCHEDULE 13G/A
Questions about IMTX
What does Immatics N.V. do?
Immatics N.V. is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker IMTX.
Is Immatics N.V. profitable?
No. In fiscal 2025 it reported a net loss of €196.4M.
When did Immatics N.V. last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on March 5, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the activist stake changed from August 27, 2026.
Similar companies
Follow IMTX
Get an email when Immatics N.V. files with the SEC: results, executive changes, material agreements and annual reports.
Follow IMTX: get an email when it filesWhere the numbers come from
Financial figures are the values Immatics N.V. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.